Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biochrom, Gilson Sign ELISA Distribution Agreement

Published: Tuesday, June 10, 2014
Last Updated: Tuesday, June 10, 2014
Bookmark and Share
Companies to co-market and distribute products for automation of ELISAs and other absorbance assays in Europe.

The partnership combines the strength of the EZ Read range of microplate readers from Biochrom, with Gilson’s innovative line of liquid handling systems. Used together the flexible offering enables scientists to easily automate their absorbance assays including ELISA, total protein and cell viability.

Biochrom created the EZ Read microplate reader range by matching its expertise in absorbance measurement with requests from scientists and technicians to make their experimental workflow easier and more effective. Gilson has incorporated its vast knowledge of liquid transfer techniques into a wide range of automated liquid handlers. 

Tristana von Will, Global Product Marketing Manager at Biochrom, commented:  “Gilson is a leader in liquid handling systems and we are delighted to be combining the heritage and expertise of both companies to co-sell our product ranges. Researchers and technicians will be very familiar with both the Biochrom and Gilson brands, but together we can further streamline experimental workflows for our customers.” 

Ronan Herry, European Marketing Director at Gilson International BV, stated:” The Biochrom range of EZ Read Microplate readers fits very well with our range of liquid handling products, either for those customers who require manual or electronic multichannel pipettes from the PIPETMAN range or for those customers that would like to automate their lab work flows. The Gilson PIPETMAX comes at a size and price that is accessible to any lab and takes away the stress and strain of manual pipetting for ELISA and Bradford type assays while improving reproducibility. Adding the Biochrom range now enables Gilson to offer a complete applications solution for our customers”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biotrak™ Assay Methods for use with Biochrom Microplate Readers
Biochrom Ltd announces increased functionality in its microplate readers that now enable users of GE Healthcare’s popular Biotrak range of immunoassay kits to download pre-programmed method definitions.
Wednesday, November 17, 2010
Biochrom Announce Sam Luke as the new Group Managing Director
Biochrom Ltd., the UK based subsidiary of Harvard Bioscience Inc., has announced the appointment of Sam Luke as its new Group Managing Director.
Thursday, November 04, 2010
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!